Lipoprotein-based drug delivery
Lipoproteins (LPs) are circulating heterogeneous nanoparticles produced by the liver and intestines. LPs play a major role in the transport of dietary and endogenous lipids to target cells through cell membrane receptors or cell surface-bound lipoprotein lipase. The stability, biocompatibility, and selective transport of LPs make them promising delivery vehicles for various therapeutic and imaging agents. This review discusses isolation, manufacturing, and drug loading techniques used for LP-based drug delivery, as well as recent applications for diagnosis and treatment of cancer, atherosclerosis, and other life-threatening diseases.
Advanced Drug Delivery Reviews
Digital Object Identifier (DOI)
Busatto, S., Walker, S. A., Grayson, W., Pham, A., Tian, M., Nesto, N., Barklund, J., & Wolfram, J. (2020). Lipoprotein-based drug delivery. Advanced drug delivery reviews, 159, 377–390. https://doi.org/10.1016/j.addr.2020.08.003